Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum.

Abstract

In this study the efficacy and safety of systemic FK 506 therapy was evaluated in four patients with severe recalcitrant pyoderma gangrenosum unresponsive to conventional therapy.